Operating Lease, Right-of-Use Asset in USD of Context Therapeutics Inc. from Q4 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Context Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2021 to Q3 2025.
  • Context Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $139K, a 43.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Context Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $139K -$106K -43.2% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $166K 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $193K 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $219K +$219K 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 $244K +$244K 30 Sep 2024 10-Q 06 Nov 2024
Q4 2023 $0 -$52K -100% 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 $0 -$73.8K -100% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $7.52K -$87.7K -92.1% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $29.9K -$86.6K -74.3% 31 Mar 2023 10-Q 10 May 2023
Q4 2022 $52K +$52K 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 $73.8K 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $95.3K 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $116K 31 Mar 2022 10-Q 11 May 2022
Q4 2021 $0 31 Dec 2021 10-K 22 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.